Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 21, 2026.

A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability

Georgia Wilke, Lisa J. Funkhouser-Jones, Yi Wang and 11 more

Cell Host & Microbe · 2019 · CC BY

doi:10.1016/j.chom.2019.05.007

Abstract

Despite being a frequent cause of severe diarrheal disease in infants and an opportunistic infection in immunocompromised patients, Cryptosporidium research has lagged due to a lack of facile experimental methods. Here, we describe a platform for complete life cycle development and long-term growth of C. parvum in vitro using "air-liquid interface" (ALI) cultures derived from intestinal epithelial stem cells. Transcriptomic profiling revealed that differentiating epithelial cells grown under ALI conditions undergo profound changes in metabolism and development that enable completion of the parasite life cycle in vitro. ALI cultures support parasite expansion > 100-fold and generate viable oocysts that are transmissible in vitro and to mice, causing infection and animal death. Transgenic parasite lines created using CRISPR/Cas9 were used to complete a genetic cross in vitro, demonstrating Mendelian segregation of chromosomes during meiosis. ALI culture provides an accessible model that will enable innovative studies into Cryptosporidium biology and host interactions.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Cryptosporidium is a gastrointestinal parasite that causes long-term illness in immunocompromised patients and contributes to malnourishment and impaired growth in children in low- to middle-income countries. Human infection is primarily caused by two species: C. parvum that is zoonotic and C. hominis that almost exclusively infects humans, while other species are much less frequently found in humans. Cryptosporidiosis is transmitted by an oral-fecal route, and the entire life cycle, consisting of asexual and sexual phases, takes place within intestinal enterocytes of a single host.

Biological investigations of Cryptosporidium have been hampered due to the lack of facile experimental platforms. Genetic modification of C. parvum using CRISPR/Cas9 requires propagation in immunocompromised mice, and stable transgenic parasites still cannot be selected or propagated in vitro due to the lack of robust cell culture platforms. Adenocarcinoma cell lines such as HCT-8 and Caco-2 support short-term growth, but the parasite does not complete its life cycle and replication ceases after a few rounds of asexual division. Because sexual recombination does not readily occur in vitro, little is known about the processes of sexual differentiation, fertilization, or meiosis in this parasite.

Studies using hollow fiber systems report complete life cycle development and passage of C. parvum in vitro, but they require specialized equipment, are not easily scalable, and are not amenable to basic imaging techniques. A recent report that described the propagation of C. parvum in organoids derived from human intestinal epithelium demonstrates that complete development is possible in culture systems that mimic the parasite’s natural niche. However, this system requires microinjection of individual organoids with oocysts and hence is not readily scalable or directly amenable to experimental manipulation. An alternative method for creating long-term primary intestinal monolayers involves plating stem cells on transwells then removing the medium from the top chamber to form an “air-liquid interface” (ALI). Here, we combined a modified ALI system with stem-cell derived spheroid cultures to develop a system that supports long-term growth and complete development of C. parvum in vitro. We further demonstrate the utility of this system by generating transgenic parasites and performing an in vitro genetic cross, confirming the Mendelian nature of meiosis and opening forward genetics in C. parvum.

ALI Monolayers Support Long-Term C. Parvum Infection In Vitro

We adopted previous methods for stem-cell derived cultures of mouse intestinal epithelial cells (mIECs) to differentiate monolayers on transwells under ALI conditions as a platform for C parvum growth in vitro (Figure 1A). Briefly, mIECs were amplified as spheroids, plated onto transwells that contained a matrigel coating and irradiated 3T3 cell feeder layer. mIECs monolayers were first grown submerged in conditioned medium (see STAR Methods) for 7 days, followed by removal of the top medium. Following the establishment of ALI conditions, cells in the monolayer underwent a burst in replication, as detected by staining with Ki-67 (Figure S1A). Additionally, cells began to express markers consistent with enterocyte and secretory cell lineages found in the small intestine, such as goblet cells and Paneth cells (Figure S1A). Electron microscopy of ALI monolayers processed at ∼ 1w-eek post top medium removal revealed the presence of a brush border and formation of tight junctions between epithelial cells at the apical side of the cells (Figure S1B). ALI cultures begin differentiating within a few days after top medium removal but do not reach full maturity until almost 14 days when the apical brush border became more prominent as detected with villin staining (Figure S1A).

To determine if ALI monolayers would support C. parvum growth, we infected monolayers with calf-derived oocysts and tracked parasite growth using microscopy and quantitative PCR (qPCR). Examination of H&E-stained sections of ALI monolayers showed a continuous monolayer of epithelial cells with a height comparable to that found in vivo (Figure 1B). Parasites were readily discernable at the apical surface of ALI monolayers examined by H&E staining or IHC (Figure 1B), consistent with their normal replicative niche in vivo, which has been described as intracellular but extracytoplasmic. Parasite growth, as measured by qPCR, showed that C. parvum increased for at least 20 days post-infection, amplifying ∼100-fold from the initial infection (Figures 1C and S1C). This level of amplification is more than 10-fold higher than what we have observed in mIECs grown on conventional transwells without ALI conditions or that is reported in adenocarcinoma cell lines. Remarkably, the high parasite density in ALI cultures did not affect overall monolayer viability as evident from qPCR of mouse genomic DNA equivalents that increased over time (Figures 1C and S1C), and visual inspection of the infected transwells did not show signs of barrier breakdown or leakage.

All Developmental Stages Of C. Parvum Occur in ALI Monolayers

To determine the extent of development of C. parvum in ALI cultures, we utilized a recently described panel of mAbs that stains intracellular stages of development. Fluorescence microscopy of infected monolayers confirmed the appearance of asexual life cycle stages of C. parvum. Trophozoites were recognized by mAb 1B5, which labels a distinctive doughnut shape around trophozoites that may reflect the modified actin pedestal beneath the parasite (Figures 1D and S2A). Type I and II meronts were identified by mAb 1A5, which stains mature merozoites within meronts in a polarized manner (Figures 1D, S2B, and S2C). Sexual stages of C. parvum appeared by day 2 post infection and were abundant in the ALI cultures. Microgamonts were identified by their multiple small nuclei (up to 16) and separate cytoplasm detected by polyclonal antibody Pan Cp, which labels all forms of C. parvum (Figures 1D and S2D). Macrogamonts were identified by the presence of secretory vesicles detected with Crypt-a-glo (Figures 1D and S2E), a commercial FITC-conjugated mAb made against C. parvum oocyst outer wall proteins, or by OW50, a mAb that stains the oocyst wall (Figure S1D). These vesicular structures are known as wall-forming bodies (WFBs), and they contain proteins that are precursors of the oocyst wall. In late-stage macrogamonts, the WFBs coalesced into a ring at the perimeter of the parasite (Figures 1D, S1D, and S2G), which may represent a postfertilization stage before oocyst formation.

When examined by electron microscopy, most parasites were found in immature enterocytes (Figure 2), although occasionally they were seen in secretory cells. Trophozoites were recognized by their distinctive, single-nucleated morphology (Figure 2A), while type I meronts were contained in round parasitophorous vacuoles containing eight merozoites (Figure 2B). Type II meronts had taller, narrower, elongated vacuoles with four merozoites (Figure 2C), and microgamonts contained clusters of small bullet-shaped parasites (Figure 2D). Macrogamonts were identified based on their numerous lipid and glycogen vacuoles within the parasite cytoplasm, as well as the striated fiber previously described in macrogamonts (Figure 2E). Oocysts surrounded by a convoluted wall were also recognized in ALI cultures by electron microscopy, although a majority of these were unsporulated (Figure 2F).

Robust C. Parvum Growth Requires ALI And Early Cell Differentiation

To determine whether ALI conditions were required for C. parvum growth, we compared C. parvum proliferation in infected “submerged” mIEC monolayers grown on transwells without removal of the top medium (non-ALI) to ALI transwells infected 3 days after removal of the top medium. C. parvum grew significantly better in ALI transwells compared to non-ALI transwells (Figures 3A and S3A), while host cell viability during infection was improved in ALI transwells compared to non-ALI transwells despite the higher infection levels in the former (Figures 3A and S3A).

To determine the influence of cell differentiation on C. parvum growth, we infected transwells on day 0 of ALI initiation vs. day 3 postmedium removal, when monolayers first begin to show signs of differentiation (Figure S1A). C. parvum grew significantly better in transwells infected 3 days after ALI initiation compared to day 0 ALI cultures, which only supported low levels of expansion (Figures 3B and S3B). Similar to the ALI vs. non-ALI experiment, host cell viability during infection was improved in the transwells infected on day 3 (Figures 3B and S3B).

The above findings suggested that enhanced C. parvum growth was tied to improved host cell viability and proliferation triggered by ALI growth conditions. To visualize cell proliferation during infection, we pulsed parallel sets of infected, submerged non-ALI and 3-day ALI cultures with EdU in the bottom chamber medium for 8 h. Microscopy showed higher numbers of both C. parvum and proliferating cells (EdU positive) in transwells infected 3 days after ALI initiation compared to the submerged non-ALI transwells (Figure 3C). Although C. parvum was primarily found in non-EdU positive cells, this pattern was not exclusive (Figure 3C). In separate experiments, we observed that ALI monolayers are permissive to infection from days 3–6, but that infection is less readily established after this time period, perhaps due to the dramatic increase in mucus production that is observed at later times points (Figure S1A). As such, for all subsequent experiment we focused on the optimal conditions of infecting ALI cultures 3 days after removal of the top medium.

ALI Culture Leads to Cellular Replication, Altered Metabolism, and Differentiation

To determine the underlying changes that occur in ALI cultures following removal of top medium, we compared RNA-seq transcriptomes of mouse ileal cells replicating as spheroid cultures to day 0 ALI (before top medium removal), day 3 non-ALI (submerged transwell cultures), and day 3 ALI cultures. Analysis of gene expression differences by principle component analysis indicated that spheroid cultures were highly different from the rest of the samples (Figure 4A), as might be expected from the differences in growth conditions (i.e., they are embedded in Matrigel in a 3-D system instead of grown on transwells). In comparing cultures grown on transwells, day 3 ALI samples clustered in a distinct group, while non-ALI day 3 and ALI day 0 samples were largely overlapping (Figure 4A). To more closely examine these changes, we compared the expression of all genes between day 3 non-ALI and ALI samples using Ingenuity Pathway Analysis (IPA) to define pathways that were significantly different (p < 0.05) between growth conditions based on concordant changes among genes within similar pathways. A subset of the most prominently differentially expressed metabolism and cell cycle pathways is illustrated in Figure 4B, highlighting the changes in glycolysis (down regulated in day 3 ALI) vs. oxidative phosphorylation and the TCA cycle (up regulated in day 3 ALI) and cell cycle and replication (up regulated in day 3 ALI). Additional changes in gene expression profiles are highlighted in Figure S4.

Histological studies indicated that secretory cell lineages started to appear as early as day 3 in ALI cultures (Figure S1A); therefore, we analyzed a subset of genes related to epithelial cell differentiation including markers for secretory cells (i.e., Paneth, goblet, and enteroendocrine cells). Genes related to the development of these intestinal cell lineages were significantly upregulated in day 3 ALI versus day 3 non-ALI cultures (Figure 4C). Additionally, stem cell markers Lgr5 and HopX were slightly decreased in day 3 ALI, while Bmi1 was elevated (Figure 4C), as were markers Sox9 and Dll1, which are highly expressed in transient amplifying cells that emerge from the crypt after being produced from intestinal stem cells. These findings are consistent with the observation that ALI cultures undergo differentiation, yet still contain proliferative cells that are labeled by EdU and Ki-67 (Figures 3C and S1A). Finally, because the transcription factor ATOH1 is significantly upregulated in day 3 ALI (Figure 4C), we tested the reliance of C. parvum growth on secretory cells that are dependent on this transcription factor for development (i.e. Paneth, goblet, enteroendocrine cells). Because Atoh1 knockout mice die shortly after birth, we generated a spheroid line from a floxed Atoh1 mouse then excised the Atoh1 gene by the introduction of Cre-recombinase in vitro (Figure S5). Inoculation of wild type (Atoh1f/f) and Atoh1 null (Atoh1−/−) ALI transwells revealed that C. parvum grew robustly in both cell lines (Figure 4D), indicating that parasite growth was not dependent on the secretory cell lineages.

ALI Monolayers Support Oocyst Development

To determine if oocysts were being produced de novo in the ALI monolayers, we infected transwells with excysted sporozoites passed through filters with a 1 μm pore size, a step we determined was essential to remove all residual input oocysts (Figure 5A). To visualize oocyst development, we stained the monolayers with Crypt-a-glo and counted the number of oocysts per field. Oocysts began to appear by day 3 and varied in frequency within different regions of the culture (i.e., 1–10 oocysts per high powered field) and across different experiments (Figure 5B), although occasionally they were quite numerous (Figure 5C). Based on the frequencies reported in Figure 5B, we estimate that each transwell contained between 100-1,000 oocysts starting 3 days post infection. However, oocyst numbers went through periodic cycles over time (Figure 5B), suggesting there are successive rounds of production followed by hatching and reinitiation of infection. To confirm the oocysts observed by staining were indeed newly produced in culture, we added EdU to the culture medium overnight and examined incorporation into the nuclei of sporozoites. We readily identified oocysts containing four EdU-positive sporozoite nuclei in the ALI monolayers (Figure 5D), confirming that the oocysts observed in ALI cultures replicated and sporulated in vitro and were not the result of contamination from the original inoculum.

It has been shown previously that C. parvum oocysts bind the GalNAc-binding lectin Maclura pomifera agglutinin (MPA) and the fucose-binding lectin Ulex europaeus agglutinin I (UEA-1). To confirm that the in vitro-produced oocysts shared these characteristics, we isolated the oocysts from the ALI monolayers by bleaching the monolayers to remove cell debris and intracellular parasites, then plated the remaining material on poly-L-lysine-coated coverslips. We stained the material with MPA and UEA-1 lectins and observed lectin-positive oocysts (Figure 5E), confirming the oocysts produced in vitro shared the normal characteristics of mature oocysts.

Oocysts Produced in Vitro are Infectious to Mice

To determine whether the oocysts produced in vitro were viable and infectious, we infected ALI monolayers with filtered sporozoites and then treated the monolayers with bleach to kill all parasites except oocysts. Bleached material stained with Crypt-a-glo showed that day 3 ALI cultures contained numerous oocysts, while day 1 cultures were negative (Figures 6A, 6B, and S6A). We then infected Ifngr1−/− mice, which are highly susceptible to C. parvum with bleached material from day 1 and day 3 cultures by oral gavage. Mice that received day 1 material survived for the duration of the experiment (Figures 6C and S6B) and did not show any evidence of oocyst shedding above the background signal in the assay (Figures 6D and S6C). Conversely, mice that received day 3 material began shedding oocysts by day 5 postgavage, and the number of oocysts increased almost two logs before the animals died (Figures 6D and S6C), which occurred by day 12 postgavage (Figures 6C and S6B). Consistent with the shedding results, intestinal tissue sections from mice that received the day 3 material showed robust infection by anti-C. parvum IHC, but no sign of infection was seen in mice inoculated with day 1 material (Figure 6E). We also initiated infection of new ALI monolayers with bleached oocysts obtained from day 3 ALI cultures, including dilutions of the material, which readily expanded at a similar rate to cultures initiated with calf-derived oocysts (Figures 6F and S6D).

Generation of Stable Transgenic Parasites

To generate transgenic parasite strains, we modified a previously described nanoluciferase (Nluc) reporter fused to neomycin resistance (NeoR) by inserting a P2A skip peptide to increase luciferase expression and by adding GFP driven by the C. parvum actin promoter (Figures 7A and S7C). Excysted sporozoites were electroporated with the TK-GFP-Nluc-P2A-neo-TK plasmid and a newly constructed Cas9 plasmid (Table S2) containing a tk guide RNA sequence, then added to ALI transwells. Eight h post infection (p.i.), extracellular parasites were washed from the top of the transwells, and bottom medium was replaced with medium containing 20 mM paromomycin (PRM) for selection or PBS control. On the first day p.i., both drug-treated and nontreated transwells had high luminescence values, indicative of transient expression (Figure 7B). By the fourth day of selection, luminescence values per parasite were 23-fold higher on average in PRM vs. PBS-treated transwells (Figure 7B), although this difference was not statistically significant. Staining with a Pan Cp polyclonal antibody that recognizes all stages of C. parvum showed that most parasites in the culture expressed GFP, indicating that selection enriched substantially for transgenic parasites (Figure 7D).

The C. parvum genome contains two uracil phosphoribosyltransferase (UPRT) enzymes capable of converting scavenged host uridine into uridine monophosphate. For a second fluorescent parasite strain, we designed a targeting construct to replace one of the C. parvum UPRT genes (cgd1_1900) with a mCherry reporter upstream of the Nluc-P2A-neo cassette described above (Figures 7E and S7F). Sporozoites electroporated with the UPRT-mCh-Nluc-P2A-neo-UPRT plasmid and a Cas9 plasmid with a UPRT gRNA were selected for growth in ALI transwells treated with 20 mM PRM. We detected an 18-fold increase in relative luminescence per parasite on average in PRM vs. PBS-treated transwells by 3 dpi, a difference that was statistically significant (Figure 7F). Immunofluorescence staining confirmed that most of the parasites expressed the mCherry transgene (Figure 7H). To generate larger numbers of oocysts, we passaged the mixed transgenic populations in immunocompromised mice under drug selection (16 g/L PRM in the drinking water) and then purified the oocysts from infected fecal pellets (Figures S7B–S7G). Using primers located inside and outside the deleted genes, we confirmed that both the TK-GFP and UPRT-mCherry strains had the correct insertion into the genomic loci and were lacking the tk and uprt genes, respectively (Figures S7E and S7H), indicating that the populations are pure transgenic lines.

Crossing Reporter Strains In Vitro Produces Viable, Recombinant Oocysts

Since the GFP and mCherry reporters were inserted into different chromosomes (5 and 1, respectively), cross-fertilization in vitro should result in recombinant progeny expressing both reporters following the first round of oocyst formation (Figure 7I). We infected ALI transwells with equal numbers of TK-GFP and UPRT-mCherry parasites, then examined cultures by microscopy at 3 to 5 dpi to detect the presence of parasites expressing both reporters (Figure 7J). In two independent experiments, yellow parasites were absent at 1 dpi but appeared by 3 or 5 dpi, consistent with the time needed for completion of the life cycle (Figure 7K).

Following crossing between TK-GFP and UPRT-mCherry parasites, oocysts should contain sporozoites of different genotypes, based on independent segregation of the chromosomes (Figure 7L). To test this prediction, we infected ALI transwells with equal numbers of TK-GFP and UPRT-mCherry sporozoites, then enriched for oocysts at 3 dpi by bleaching transwells. We recovered and plated the oocysts on a human adenocarcinoma cell line (HCT-8) at a low MOI such that parasites descended from a single oocyst would form separate clusters as they grew out. If the oocyst was a result of self-fertilization, then all parasites in a cluster were expected to express the same color (either green or red), whereas cross-fertilization events should produce clusters of parasites with mixed phenotypes. After a single round of merogony during the outgrowth phase (15–18 hpi), we observed that 20.6%–27.9% of clusters had parasites with mixed phenotypes, depending on the experiment (Figure 7M), confirming that they arose from the product of outcrossing. This value is significantly lower than expected, presumably due to the localized nature of infection in the transwells that limited outcrossing rather than an intrinsic defect in fertilization, as both lines productively underwent self-fertalization in mice (Figure S7). The contents of oocysts formed from out-crossing are expected to initially express both markers and to be yellow as the sporozoites are formed from a commonly inherited cytoplasm. However, as parasites grow out from individual sporozoites, their phenotype (i.e., colors) will reflect the genotypes they inherited in the cross, as diagrammed in Figure 7L. Importantly, the distribution of different genotypes, and hence color patterns, among parasites from these mixed clusters did not significantly deviate from the expected frequency of 25% for each phenotype (Figure 7N).

Discussion

Our findings establish that cultivation of stem-cell derived intestinal epithelial cells under ALI conditions enables complete development of the C. parvum life cycle and provides a platform to investigate host-parasite interactions using forward and reverse genetics. In a separate report (Wang and Stappenbeck, unpublished), the use of ALI culture conditions as employed here is shown to induce a critical population of HopX-positive stem cells that drives regeneration, differentiation, and restores gut homeostasis. Following the switch to ALI culture conditions, mIEC monolayers underwent dramatic expansion and differentiation from stem cells to resemble cell lineages normally found in the intestine. Expansion of parasites did not appear to adversely influence the integrity of the monolayer, perhaps because of the continual renewal of cells from stem cells. Although the infection was seen in all cell types, C. parvum grew equally well in Atoh1−/− cultures, which lack the capacity to develop the secretory cell lineages. Similarly, C. parvum infection is not restricted to a specific cell type in the intestine, although it occurs primarily in enterocytes.

Analysis of gene expression data revealed profound changes in metabolism in ALI cultures to favor oxidative phosphorylation over glycolysis. This change is intriguing as adenocarcinoma cells, which only support limited growth of C. parvum, are also highly glycolytic, a phenotype common to many cancer cells known as the Warburg effect. When mIECs were cultured in the presence of the top medium, this metabolic shift was not evident, and they only supported modest growth. The data suggest that changes in host cell metabolism are key for supporting optimal growth and complete development of C. parvum, although further studies would be needed to test this hypothesis. Collectively, ALI monolayers likely support C. parvum growth in vitro because they resemble the in vivo niche of the parasite in terms of gene expression, metabolism, and differentiation state.

In addition to all previously described asexual and sexual stages, we identified a stage we termed “late-stage macrogamonts” in which WFBs organized in a circular pattern at the perimeter of the cell. A similar process occurs during formation of the oocyst wall in the related coccidian Eimeria, suggesting that these “late-stage macrogamonts” may represent zygotes of C. parvum that form in ALI but not conventional cell cultures. Mature oocysts appeared by day 3 post-infection and were present in cyclical waves, suggesting they do not accumulate as a mature end stage, but rather excyst to reinitiate infection. Oocysts exhibited features of the mature oocyst wall including lectin staining, were bleach-resistant, and were infectious to naive monolayers and to mice, leading to robust oocyst shedding.

The growth of C. parvum in ALI transwells has several advantages over alternative in vitro methods described previously. For example, ALI transwell cultures grown in microtiter format can be easily scaled (e.g., multiples of 12 transwells can be plated simultaneously) to test multiple conditions in parallel. The availability of long-term growth in ALI monolayers also facilitates genetic approaches in C. Parvum, as demonstrated using CRISPR/Cas9, to generate transgenic parasites in vitro that were then further amplified in the mouse. The ability of C. parvum to complete the entire life cycle in ALI cultures was also used to perform genetic crosses in vitro, something currently not possible with other apicomplexan parasites. To fully capitalize on this development, it would be advantageous to develop methods for serial propagation, for the generation of single cell clones, and for regulatable systems to study essential genes. Such barriers have rapidly eroded where efforts have been applied in other parasitic parasites, and they are likely to do so here as well.

The segregation pattern of independent markers on different chromosomes observed following in vitro genetic crosses of C. parvum is consistent with the fusion of haploid gametes followed by independent segregation of chromosomes, as predicted by Mendelian genetics. A survey of the highly reduced C. parvum genome indicates that it retains nearly all of the conserved genes within the meiotic tool box (Table S1). The ability to recover all four progeny from each meiotic event could facilitate future studies to understand the meiotic division processes used by apicomplexans. Additionally, genetic mapping and linkage analysis should be useful for forwarding genetic analysis of complex traits in C. parvum. In this regard, the ability of C. parvum to complete its entire life cycle and undergo meiosis within 3 days within a single in vitro culture offers considerable advantages over other parasitic systems that must rely on multiple invertebrate and/or vertebrate hosts to perform such genetic crosses.

Contact for Reagent and Resource Sharing

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, L. David Sibley (sibley@wustl.edu).

Cryptosporidium Strain

C. parvum oocysts (AUCP-1 isolate) were maintained by repeated passage in male Holstein calves and purified from fecal material after sieve filtration, Sheather’s sugar flotation, and discontinuous sucrose density gradient centrifugation as previously described. All calf procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Illinois Urbana-Champaign. Purified oocysts were stored at 4°C in PBS + 50 mM Tris-10 mM EDTA, pH 7.2 for up to six months before use.

Cell Lines

All cell lines were cultured at 37°C in a 5% CO2 incubator under normal atmospheric oxygen conditions. Primary ileal intestinal epithelial stem cells (IECs) isolated from 8-10-week-old female C57BL/6 mice (Stappenbeck laboratory, Washington University School of Medicine) were expanded and maintained as 3D spheroid cultures in Matrigel (BD Biosciences) and 50% L-WRN conditioned medium (CM) containing 10 μM Y-27632 ROCK inhibitor (Tocris Bioscience), as described previously. L-WRN-CM was quality controlled form batch to batch using recently defined methods. The medium was changed every 2 days, and the cells were passaged every 3 days in a 1:6 split. IEC lines were determined to be mycoplasma-negative using the e-Myco plus kit (Intron Biotechnology). For all experiments in this study, IECs were used between passages 4 and 26.

NIH/3T3 embryonic mouse fibroblast cells (ATCC, CRL-1658™) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM high glucose; Sigma D6429) with 10% fetal bovine serum (Sigma) and 1X penicillin/streptomycin (Sigma). Cells were passaged every 3 days in a 1:5 split.

HCT-8 human colorectal adenocarcinoma cells from a male patient (ATCC, CCL-244) were maintained in RPMI 1640 ATCC Modification medium (Thermo Fisher Scientific A1409101) supplemented with 10% fetal bovine serum (Sigma). Cell were passaged twice a week at a 1:5 – 1:20 split.

Mouse Lines

For the bleach, ALI infectivity assays, female 8- to 10-week-old Ifngr1-/- mice (C57BL/6 genetic background) were purchased directly from Jackson Laboratories (#003288) and housed separately for the duration of the experiment to avoid cross-infection. For amplification of transgenic C. parvum parasites, male and female 7- to 14-week-old Ifngr1-/- mice and male and female 12- to 17-week-old Nod scid gamma mice (NSG™, Jackson Laboratories #005557) were bred in house at Washington University School of Medicine and co-housed based on sex. Mice were reared in a specific-pathogen-free facility on a 12:12 light-dark cycle and received irradiated laboratory rodent chow (Purina 5053) and water ad libitum. For amplification of transgenic parasites, water was replaced with filtered tap water containing 16 g/L paromomycin sulfate salt (Sigma). Animals that lost more than 20% of their body weight or became non-ambulatory during the course of infection were humanely euthanized in a SMARTBOX Auto CO2 euthanasia chamber. All mouse studies were approved by the Institutional Animal Studies Committee at the School of Medicine, Washington University in St. Louis.

Irradiating 3T3 Fibroblast Cells

Mouse fibroblast cells (NIH/3T3; CRL-1658™ ATCC) were trypsinized, suspended in growth medium, and irradiated at 3,000 rads using the Small Animal Radiation Research Platform (SARRP, Xstrahl). After cell viability was assessed with Trypan Blue staining (Thermo Fisher), irradiated cells were quantified, aliquoted in freezing medium (growth medium with 30% FBS and 5% DMSO) and stored at -80°C for short-term use (weeks) or in liquid nitrogen for long-term use (months).

Seeding Irradiated 3T3 Feeder Cell Layer on Transwells

Transwells (polyester membrane, 0.4 μm pore; Corning Costar) were coated with Matrigel (Corning) diluted 1:10 in cold PBS, then incubated at 37°C for 15-20 min. Excess Matrigel solution was aspirated immediately before adding irradiated 3T3 (i3T3) cells, which were thawed, resuspended in growth medium, and seeded onto transwells at 8x104 cells/ transwell. Growth medium was added to the top and bottom of the transwell and incubated at 37 °C for approximately 24 hr before seeding the mIEC spheroids.

Seeding the Mouse Intestinal Epithelial Cell Monolayers and Creating Airliquid Interface

Mouse ileal spheroids from 3-day-old stem cell cultures were recovered from Matrigel and dissociated with trypsin as described previously. Cells were quantified, suspended in 50% CM with 10 μM Y-27632, and plated onto i3T3 monolayers at 5x104 cells/ transwell. 3T3 growth medium was replaced with 50% CM with 10 μM Y-27632 in both the top and bottom compartments and replenished every other day. After 7 days, the medium in the top compartment was removed to create the air-liquid interface (ALI). Medium in the bottom compartment of the transwell continued to be changed every other day. Liquid/mucus that appeared in top compartment was removed every other day.

Generating Mouse Atoh1-/- Knockout Spheroid Lines

Spheroids were established from the jejunum of Atoh1 flox mice (Jackson Laboratory Stock # 008681). For Tat-Cre mediated recombination, 5 μM Tat-Cre recombinase (Millipore Sigma) was added to a single-cell suspension of spheroid epithelial cells in 50% L-WRN CM with 10 μM ROCK Inhibitor (Y-27632; Tocris Bioscience) overnight. The following day, the cells were pelleted, plated in Matrigel containing 1 μM Jag1 peptide (AnaSpec), and cultured as described above. Single spheroids were selected, expanded, and then genotyped for recombination of the flox alleles by PCR with the following primers: Atoh1-P1 5’-GCGCAGCGCCTTCAGCAACC-3’; Atoh1-P2 5’-GACCTGTCGCCTTCGCTGCC-3’; Atoh1-P3 5’-GCGCGCTAGGAAGGGCATTTGG-3’.

RNA Collection and Purification

RNA was harvested from uninfected transwells seven days post IEC seeding on the day of top medium removal (ALI D0), ten days post IEC seeding with continuous top medium (non-ALI), and ten days post IEC seeding with three days of ALI (ALI D3). To collect RNA, transwells were scraped in RLT buffer (QIAGEN) + 10 μl/ml 2-mercaptoethanol, transferred to a Qiashredder column (QIAGEN), spun at max speed for two mins, then stored at -80 °C until further processing. Two transwells were combined per column with two replicates at each timepoint from two independent experiments for a total of 12 samples. Concurrently, RNA from stem-cell spheroids were harvested 3 days post seeding, one well per Qiashredder column, two replicates per experiment from two independent experiments for a total of four spheroid samples. RNA was extracted and purified from all samples using the RNeasy Mini kit (QIAGEN) then treated with the DNase DNeasy kit (Thermo Fisher Scientific) to remove residual DNA.

Library Preparation and Sequencing

Total RNA was submitted to the Genome Access Technology Center (Washington University School of Medicine) for library prep and sequencing. RNA integrity was determined using an Agilent Bioanalyzer and ribosomal RNA was removed using a Ribo-ZERO kit (Illumina-EpiCentre). mRNA was then fragmented and reverse-transcribed using the SuperScript III RT enzyme (Life Technologies) and random hexamers. A second strand reaction was performed to yield ds-cDNA, which was then blunt-ended and ligated to Illumina sequencing adapters. Ligated fragments were amplified for 12 cycles using primers incorporating unique index tags. Two biological replicates per sample (eight samples total) were multiplexed for single-end, 50 bp reads on a single lane of an Illumina HiSeq3000. To increase coverage and sample size, the other two biological replicates per sample were independently processed and sequenced with identical parameters to the first set.

Demultiplexed fastq files were imported into Partek Flow (Partek, Inc.) with a mean of 43,115,081 reads per sample (range: 31,092,799 – 50,130,171 reads). Five bases were trimmed from the 5′ end of all reads to increase the average quality score across samples from 38.92 to 39.45. Trimmed reads were then mapped to the Mus musculus mm10 genome build (NCBI GenBank assembly ID GCA_000001635) using the STAR aligner with default parameters, and the number of reads per gene was quantified based on the mouse Ensembl Transcripts release 90. On average, 88.9 ± 6.1% (mean ± S.D.) of reads per sample were mapped to the genome with an average coverage of 577.76 reads per gene (13,889 genes total).

Analysis of RNA-Seq Data

For differential expression analyses, we first normalized gene expression values by dividing the number of reads per gene by the total number of reads per sample to obtain counts per million (CPM) values. These normalized expression values were used in a principal component analysis to visualize the variation in expression differences between all replicates and sample types. Pair-wise comparisons of sample types (4 replicates each) were performed using the Partek gene-specific analysis (GSA) algorithm, which is a multimodel approach that determines the best response distribution (e.g. lognormal, Poisson, or negative binomial) for each gene based on Akaike information criteria (AICc) model selection rather than fitting all data to one distribution. Genes were not included in the analysis if their mean CPM value over all samples was less than 1. Genes were considered significantly differentially expressed if the FDR-corrected P value was less than 0.05 and the absolute fold change was greater than 2.

For molecular pathway analyses of day 3 ALI and non-ALI samples, the expression fold change and FDR-corrected P value for all genes from Partek Flow were imported into Ingenuity Pathway Analysis (QIAGEN). A core analysis was performed using the Ingenuity Knowledge Database to identify canonical pathways and gene networks that changed significantly (Z-score < 0.05) under ALI growth conditions. A separate core analysis was also performed using as input only genes that were significantly differentially expressed between day 3 ALI and non-ALI (FDR-corrected P value < 0.05, absolute fold change > 2).

C. parvum Oocyst Preparation, Excystation, and Infection of ALI Transwells

Before infection, purified C. parvum oocysts were treated with a 40% bleach solution (commercial laundry bleach containing 8.25% sodium hypochlorite) diluted in Dulbecco’s Phosphate Buffered Saline (DPBS; Corning Cellgro) for 10 min on ice. Oocysts were then washed 4 times in DPBS containing 1% (wt/vol) bovine serum albumin (BSA; Sigma) before resuspending to a final concentration of 1x108 oocyst/ml in DPBS with 1% BSA. For some experiments, oocysts were excysted prior to infection by incubating the oocysts with 0.75% sodium taurocholate (w/v; Sigma) in DPBS at 37°C for 60 min. As indicated, excysted oocysts were filtered through a membrane with 1 μm pore size (Whatman, VWR International) to remove unexcysted oocysts from sporozoites. Sporozoites were spun down at 1,250 x g for 3 min and then resuspended in 50% CM prior to adding to ALI monolayers. Oocysts or filtered sporozoites were added to monolayers in 30 μl of 50% CM three days post top medium removal. After 3 hr, monolayers were washed twice with DPBS to remove extracellular parasites and re-establish the air-liquid interface.

Measuring C. parvum Growth and Host Cell Viability by qPCR

To monitor infection by quantitative PCR, DNA was collected and purified from infected transwells using the QIAamp DNA Mini kit (Qiagen). Briefly, 100 μl Buffer ATL (provided by kit) was added to monolayer, then cells were scraped into buffer using a blunt pipette tip. Lysed cells were incubated in Buffer ATL and proteinase K (both reagents provided by kit) in a 56°C water bath for 3-24 hr before column purification. Purified DNA was eluted in 100 ul Buffer AE then diluted 1:10 with H2O. Two μl of the diluted DNA was used as template in a qPCR reaction with TB Green™ Advantage® qPCR premix (Takara, Clontech). Primer sequences targeting C. parvum GAPDH were as follows: forward primer 5’-CGGATGGCCATACCTGTGAG-3’ and reverse primer 5’-GAAGATGCGCTGGGAACAAC-3’. A standard curve for C. parvum genomic DNA was generated by purifying DNA from a known number of oocysts and creating a dilution series. Primer sequences targeting mouse GAPDH were as follows: forward primer 5’-GCCATGAGTGGACCCTTCTT-3’ and reverse primer 5’-GAAAACACGGGGGCAATGAG-3’. A standard curve for mouse genomic DNA was generated by purifying DNA from a known number of mouse ileal stem cells and creating a dilution series. Reactions were performed on a QuantStudio 3 Real-Time PCR System (Thermo Fisher) with the following amplification conditions: priming at 95°C for 2 min then 40 cycles of denaturing at 95°C for 10 sec, annealing at 60°C for 20 sec, extension at 72°C for 30 sec, followed by a melt curve analysis to detect non-specific amplification. Genomic DNA equivalents in each sample were determined by the QuantStudio Design & Analysis software based on the standard curve samples present on each plate.

Bleaching ALI Monolayers for Microscopy, Animal Infection and In Vitro Passage

ALI monolayers were infected on day 3 post top medium removal with filtered sporozoites. After 2 hr, monolayers were washed twice with DPBS. On specified days post infection, monolayers were scraped into cold 40% bleach diluted in DPBS, combined into a single Eppendorf tube, and bleached on ice for 10-15 min before spinning down at maximum speed for 2 min. The bleach solution was removed, and the pellet was washed 6 times in 1 ml cold DPBS, repeating the centrifugation step each time, before resuspending in the desired volume of cold DPBS.

Generating the Pan Cp Polyclonal Antiserum

Antigen for the pan Cp polyclonal antiserum was generated by excysting 8 x 108 bleached oocysts in 0.75% sodium taurocholate at 37°C for 1 hr; excysted oocysts were then freeze-thawed 6 times (3 min on dry ice mixed with ethanol, then 3 min at 37°C). Sample was sent to Covance (Princeton, N.J, USA) for immunization. One rabbit was injected subcutaneously with 250 mg antigen with Freund’s Complete Adjuvant (FCA) then boosted three times at 21-day intervals with 125 mg antigen in Freund’s Incomplete Adjuvant (FIA). All immunofluorescent staining experiments used the terminal bleed pan Cp antiserum at a 1:1,000 dilution.

Immunofluorescence Microscopy

Transwells were moved to a new 24-well plate with DPBS in the bottom chamber. Monolayers were fixed by adding 100 μl 4% formaldehyde (Polysciences) for 10-15 min. Cells were washed twice with DPBS and then permeabilized and blocked with DPBS containing 1% BSA and 0.1% Triton X-100 (Sigma) for 20 min. Primary antibodies were diluted in blocking buffer for staining: 1B5 and 1A5 (purified mouse mAbs) were used at 1:500, pan Cp (rabbit pAb) was used at 1:1000, Crypt-a-glo™ (mouse mAb, Waterborne, Inc) was used at 1 drop per 2 transwells, and 4D8 (hybridoma supernatant) was used at 1:5.Cells were incubated with primary antibodies for 60 min at room temperature, washed twice with PBS, then incubated for 60 min at room in secondary antibodies conjugated to Alexa Fluor dyes (Thermo Fisher Scientific) diluted 1:1,000 in blocking buffer. Nuclear DNA was stained with Hoechst (Thermo Fisher Scientific) diluted 1:1,000 in blocking buffer for 10 mins at room temperature, then the membrane was cut out of the transwell insert using a scalpel and mounted on a glass slide with Prolong Diamond Antifade Mountant (Thermo Fisher Scientific).

For lectin staining of bleached ALI monolayers, bleached material was pipetted onto 0.01% poly-L-lysine (Sigma) treated coverslips in a 24-well plate (150-200 μl total volume per well), allowed to settle for 30 min, then fixed and permeabilized as described above. Coverslips were stained with specified lectin for 30 minutes, followed by pan Cp staining for 60 min and secondary antibody staining for 60 min, all at room temperature. Lectins used were FITC-conjugated Maclura pomifera (MPA) lectin (E Y Laboratories, F-3901-1) and FITC-conjugated Ulex europaeus (UEA-1) lectin (E Y Laboratories, F-2201-2), both used at 100 μg/ml.

For EdU staining of replicating DNA, 10 μM EdU was added to medium in the bottom chamber of the transwell. After a defined time period, the transwell was fixed with 4% formaldehyde and permeabilized as described above. EdU was labeled with the Click-iT Plus EdU Alexa Fluor 488 (Thermo Fisher Scientific, C10637) or 594 (Thermo Fisher Scientific, C10339) Imaging Kits. Primary and secondary antibody staining were done after EdU labeling.

Imaging was performed on a Zeiss Axioskop Mot Plus fluorescence microscope equipped with a 100X, 1.4 N.A. Zeiss Plan Apochromat oil objective and an AxioCam MRm monochrome digital camera. Images were acquired using Axiovision software (Carl Zeiss Inc.) and manipulated in ImageJ or Photoshop.

Sectioning and Staining Transwells for Histology

Transwells were treated with 4% formaldehyde or 4% paraformaldehyde in both top and bottom chambers for 20 min at room temperature, washed three times in 70% ethanol, then incubated for 20 min in 70% ethanol (top and bottom chambers). The transwell membranes were cut from the insert using a scalpel and embedded in 1% agar and then processed for paraffin embedding. For hematoxylin and eosin (H&E) staining and immunohistochemistry, five μm transverse sections were cut and processed for staining following standard procedures of the Digestive Disease Research Core Center (DDRC, Washington University in St. Louis). Sections were imaged using a Zeiss Observer.D1 inverted wide-field fluorescence microscope with Axiocam 503 dual B/W and color camera.

For immunostaining, slides were deparaffinized, and antigen retrieval was performed with Trilogy. Slides were then stained as described above using the following antibodies: mouse anti-villin (1:1000, Abcam) with goat anti-mouse IgG Alexa Fluor 488 (Thermo Fisher Scientific); rabbit anti-Chromogranin A antibody (1:1000, Abcam), rabbit anti-mucin 2 (1:200, SantaCruz), and rabbit anti-Ki-67 (1:400, Abcam) with goat anti-rabbit IgG Alexa Fluor 568 (Thermo Fisher Scientific); goat anti-lysozyme (1:100, SantaCruz) with donkey anti-goat IgG Alexa Fluor 568 (Thermo Fisher Scientific); and Hoechst for nuclear staining. Images were taken using a 40x oil immersion objective (N.A. 1.30) on a Zeiss Axioskop 2 equipped for epifluorescence.

Transmission Electron Microscopy

For ultrastructural analyses, ALI cultures were fixed in a freshly prepared mixture of 1% glutaraldehyde (Polysciences, Inc) and 1% osmium tetroxide (Polysciences, Inc.) in 50 mM phosphate buffer at 4°C for 30 min. Samples were then rinsed multiple times in cold dH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella Inc.) at 4°C for 3 hr. Transwell membranes were removed from insert using a scalpel. Following several rinses in dH20, samples were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella, Inc.). Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems, Inc.), stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA, Inc.) equipped with an AMT 8-megapixel digital camera and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques).

Testing Infectivity of Bleached ALI Cultures in Ifngr1-/- Mice

Female 8- to 10-week-old Ifngr1-/- mice from Jackson Laboratories were orally gavaged with 200 μl of bleached ALI material (equivalent to 4-5 transwells) from either day 1 (n = 4 mice) or day 3 (n = 4 mice) post-infection cultures. After gavaging, mice were housed separately for the duration of the experiment to avoid cross-infection. One mouse infected with bleached, day 1 ALI culture material was sacrificed on day 30 post-infection and one mouse infected with bleached, day 3 ALI culture material was sacrificed on day 9 post-infection to collect the small intestine for histology as described above. Mouse pellets were collected every 2-3 days, and the mice were monitored for signs of sickness. Mouse pellets were kept at -80°C until they were processed for DNA extraction, which was performed using the QIAamp DNA Stool Kit (QIAGEN). Pellets were moved to Lysing Matrix E 2 ml tubes (MP Biomedicals) and 1.4 ml ASL Buffer (from kit) was added. Samples were homogenized using the FastPrep-24™ 5G High-Speed Homogenizer, then processed according to the kit’s directions. qPCR was used to quantify the number of C. parvum genomic DNA equivalents present in the sample using the C. parvum GAPDH primers and cycling protocols as described above.

Cloning of C. parvum CRISPR/Cas9 and Targeting Plasmids

To generate a CRISPR/Cas9 plasmid for use in C. parvum, we used restriction cloning with SacI to insert the C. parvum U6 gene into a pUC19 vector (New England Biosciences) to create pUC19-CpU6. We then inserted the C. parvum actin promoter (984 bp upstream of cgd5_3160) upstream of Cas9-NLS-GFP, followed by the C. parvum actin 3’ UTR region (562 bp downstream of cgd5_3160) into puc19-CpU6 by Gibson assembly (New England Biosciences) to create pACT1:Cas9-GFP. This plasmid (pACT1:Cas9-GFP) was further modified by inserting the thymidine kinase (TK, cgd5_4440) guide RNA (sgRNA) and the tracrRNA amplified from the Aldolase_Cas9 plasmid downstream of the CpU6 promoter using Gibson assembly to create pACT1:Cas9-GFP, U6:sgTK (Addgene 122852). The plasmid pACT1:Cas9-GFP, U6:sgUPRT (Addgene 122853) was generated by replacing the TK sgRNA with a sgRNA targeting the C. parvum uracil phosphoribosyltransferase gene (uprt, cgd1_1900) using Q5 site-directed mutagenesis (New England Biosciences). The UPRT sgRNA was designed using the Eukaryotic Pathogen CRISPR guide RNA/DNA Design tool (http://grna.ctegd.uga.edu) searching against the C. parvum IowaII CryptoDB-28 genome to avoid off-target effects.

To generate tk knockout mutants that express GFP, we made a TK-GFP-Nluc-P2A-neo-TK targeting plasmid by first deleting the Cas9 and NLS sequences from the pACT1:Cas9-GFP plasmid described above using Q5 mutagenesis. This generated a GFP construct expressed under the C. parvum actin promoter that was then inserted between the 5’ tk homology flank and the enolase-Nluc-neoR reporter in the previously published C. parvum tk targeting plasmid by Gibson assembly. A P2A skip peptide was inserted between the nanoluciferase and neomycin resistance CDS by Q5 mutagenesis, then the entire construct was subcloned into a high copy-number vector (pUC19) to increase plasmid yield. To make uprt knockout mutants that express mCherry, we edited the tk targeting construct by swapping the GFP CDS with mCherry from pLoxP-DHFR-TS-mCherry using Gibson assembly and replacing the tk homologous flanks with uprt homologous flanks (800 bp upstream and 913 bp downstream of cgd1_1900) by restriction cloning with XmaI and PstI (New England Biosciences).

Transfection of C. parvum Sporozoites and Selection in ALI

Oocysts were excysted as described above (1.25 x 107 oocysts per cuvette), then sporozoites were pelleted by centrifugation and resuspended in SF buffer (Lonza) containing 50 ug targeting plasmid and 30 ug CRISPR/Cas9 plasmid for a total volume of 100 μl. Sporozoites were then transferred to a 100 μl cuvette (Lonza) and electroporated on an AMAXA 4D-Nucleofector System (Lonza) using program EH100. Electroporated sporozoites were transferred to 50% L-WRN conditioned medium then added to the top of eight ALI transwells per cuvette (30 μl volume, approx. 6.25 x 106 sporozoites per transwell). At 8 hpi, top media was removed, transwells were washed 2X on top with sterile DPBS, and bottom media was replaced with 50% CM + 20 mM paromomycin (Sigma) with 1M NaOH added to bring the pH to ∼7.4. Bottom media with drug was replaced every two days.

Amplifying Transgenic Parasites in Immunodeficient Mice

Transgenic parasites were drug-selected for 5 – 7 days in ALI transwells with paromomycin in the bottom medium before transferring to mice for amplification. To prepare samples for gavage, 1 – 2 transwells per mouse were scraped in DPBS, combined in a single Eppendorf tube, and syringe-lysed five times with a 20-gauge needle, then five times with a 23-gauge needle. Sample volume was brought up to 200 μl per mouse in DPBS and orally gavaged into 3 – 4 Infgr1-/- mice per transgenic C. parvum line. Mice infected with same transgenic parasite strain were co-housed but separated by sex. All mice received drinking water with 16 g/L paromomycin for the entirety of the experiment. Paromomycin dose was based on published protocols for selecting transgenic C. parvum strains in vivo. Fecal pellets were collected in microcentrifuge tubes every 3 days for qPCR (stored at -80°C) and luciferase assays (4°C) and extra fecal pellets were collected and stored at 4°C starting 6 dpi. Mice were euthanized by CO2 asphyxiation once they became overtly ill, immobile, or lost 20% of their body weight.

A second round of amplification was performed by orally gavaging 3 – 4 Nod scid gamma (NSG) mice per transgenic line with a fecal slurry from the infected Ifngr1-/- mice. Fecal slurries were produced by grinding a single pellet (9 dpi) in DPBS, then centrifuging at low speed (200 rpm) for 10 mins to pellet large particulates. The supernatant was then diluted in DPBS to achieve a concentration of approx. 1 x 104 oocysts per mouse based on the number of oocysts per mg feces for a separate pellet from the same mouse on the same day as measured by qPCR. Experimental setup and execution were the same as with Infgr1-/- mice, including selection with 16 g/L paromomycin drinking water for the entirety of the experiment. Fecal pellets for oocyst purification were collected every day starting 12 dpi and stored at 4°C. For purification, fecal samples from all mice were pooled and oocysts extracted as previously described. Purified oocysts were stored in PBS at 4°C and used within six months of extraction.

Luciferase Assay

All luciferase assays were performed with the Nano-Glo Luciferase Assay kit (Promega). For infected ALI cultures, transwells were incubated in 100 μl Nano-Glo Luciferase buffer (top compartment only) at 37°C for 15 mins. Cells were then scraped from the transwell membrane with a blunt pipette tip and transferred to a single well of a white 96-well plate (Greiner Bio-One). 100 μl of a 25:1 Nano-Glo Luciferase buffer to Nano-Glo Luciferase substrate mix was added to each well, and the plate was incubated for 3 min at room temperature. Luminescence values were read on a Cytation 3 Cell Imaging Multi-Mode Reader (BioTek). For mouse fecal pellets in 1.7 ml microcentrifuge tubes, pellets were ground with a pestle, then 3-mm glass beads (Fisher Scientific) and 1 ml fecal lysis buffer (50 mM Tris pH7.6, 2 mM DTT, 2 mM EDTA pH 8.0, 10% glycerol, 1% Triton X-100 prepared in water) were added to the tube. Tubes were incubated at 4°C for 30 mins, vortexed for 1 min, then spun at 16,000 x g for 1 min to pellet debris. 100 μl supernatant was added to two wells of a white 96-well plate, then substrate addition and luminescence reading was performed as above.

Fecal Pellet DNA Extraction, Oocyst Quantification and Insert PCR

For DNA extraction from fecal pellets, each frozen pellet was transferred to a 2 ml tube containing Lysing Matrix E beads (MP Biomedicals) and 1.4 ml ASL buffer (Qiagen), then homogenized using a FastPrep-24 5G benchtop homogenizer (MP Biomedicals). DNA was extracted after homogenization using the QIAamp DNA stool kit (Qiagen) according to manufacturer’s protocols. Oocyst numbers were quantified using qPCR with the C. parvum GAPDH primers as described above. To check for the successful insertion of the target sequence into either the tk or uprt locus, PCR was performed on 1 μl purified fecal DNA using Q5 Hot Start High-Fidelity 2X master mix (New England Biosciences) with primers listed in Table S2 at a final concentration of 500 nM each. PCR reactions were performed on a Veriti 96-well Thermal Cycler (Applied Biosystems) with the following cycling conditions: 98°C for 30 secs, followed by 35 cycles of 98°C for 15 secs, 64°C for 30 secs, and 72°C for 1.5 mins, with a final extension of 72°C for 2 mins. PCR products were run on 1.5% agarose gel containing GelRed (Biotium, diluted 1:10,000) and imaged on a ChemiDoc MP Imaging System (Bio-Rad).

Crossing Transgenic C. parvum in ALI and Quantifying Recombination Events

ALI transwells were infected three days post media removal with 5 x 104 TK-GFP and 5 x 104 UPRT-mCh oocysts (bleached and excysted as described above) in 30 μl 50% L-WRN conditioned medium added to the top compartment. Approximately six hpi, parasites were removed, and the top compartment was washed twice with sterile DPBS. At 1, 3 and 5 dpi, transwells were fixed in 4% formaldehyde and stained for immunohistochemistry as described above using polyclonal rabbit anti-GFP (Thermo Fisher Scientific) with goat anti-rabbit IgG Alexa Fluor 488 secondary and a monoclonal rat anti-mCherry 16D7 (Thermo Fisher Scientific) with goat anti-rat IgG Alexa Fluor 568. All antibodies were diluted 1:1000 in PBS + 0.1% Triton-X + 1% BSA. To quantify recombinant parasites expressing both GFP and mCherry, fields of mixed red and green parasites were imaged at random using a 63X oil immersion objective on a Zeiss Axioskop 2 equipped for epifluorescence. Red and green channels were then merged in ImageJ, and the number of yellow parasites per field was recorded. 13 – 26 fields were imaged from 1-2 transwells per experiment, and the experiment was performed twice.

To determine the frequency of oocysts produced from selfing versus crossing events, transwells were infected with TK-GFP and UPRT-mCh oocysts as described above. Three days p.i., 4 – 6 infected transwells were scraped and bleached as described above. Bleached material was used to infect two coverslips that had been plated with 4 x 105 HCT-8 cells (ATCC CCL-244) 24 hrs prior to infection. Approximately 16 hpi with the bleached ALI material, HCT-8 coverslips were fixed and stained as described above with rabbit anti-GFP and goat anti-rabbit IgG Alexa Fluor 488; rat anti-mCherry and goat anti-rat IgG Alexa Fluor 568; and mouse monoclonal antibody 1E12 and goat anti-mouse IgG Alexa Fluor 647, which detects all intracellular stages of C. parvum. Oocysts from the bleached material were plated at a low enough MOI that parasites originating from a selfing event versus a crossing event could be distinguished by the formation of parasite “clusters” containing parasites of all one color (selfing event) or with more than one color (crossing event). For clusters with parasites of more than one color, the number of parasites expressing GFP only (green), mCherry only (red), both reporters (yellow), or no reporter (“wild type” identified by staining with 1E12) per cluster was recorded. The number of each type of parasite was summed across all clusters per coverslip and expressed as a ratio of the total number of parasites counted. Data depicts results from two independent experiments.

Quantification and Statistical Analysis

All statistical analyses were performed in GraphPad Prism 7 (GraphPad Software) unless otherwise specified. Non-parametric tests were used when available if data did not pass a Shapiro-Wilk test for normality or sample sizes were too low. A Mann Whitney U test was used when comparing the mean of two groups, while a Kruskal-Wallis test with a Dunn’s multiple comparisons test was used when comparing the means of one variable across three or more groups. When comparing the means of two or more groups across time, we used a two-way ANOVA corrected for multiple comparisons using either the Sidak method if means from two groups at the same time point were compared to each other or the Dunnett method if means for all time points were compared to the mean of the earliest time point. Statistical parameters for each experiment including statistical test used, technical replicates (n), independent biological replicates (N) and standard error are reported in the figure legends and associated method details.

Blinding and Inclusion/Exclusion

Samples were not blinded for analysis although they were repeated independently as stated in the text and figure legends. All samples were included in the analysis with one exception: In the RNA-seq studies, one of the spheroid samples had a high percentage of reads map to intergenic regions (38.03% of reads) indicative of DNA contamination, and hence it was removed from further analyses.

Data and Software Availability

Raw RNA-seq reads and analyzed data generated in this study have been deposited in the Gene Expression Omnibus database under accession numbers GSM3554371-GSM3554385. The plasmids pACT1:Cas9-GFP, U6:sgUPRT and pACT1:Cas9-GFP, U6:sgTK have been submitted to Addgene and accession numbers are pending.

References 48

  1. 1.

    Arrowood M.J. In vitro cultivation of cryptosporidium species. Clin. Microbiol. Rev. 2002;15:390-400.

    Not in our library10.1128/cmr.15.3.390-400.2002

  2. 2.

    Arrowood M.J., Sterling C.R. Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection. J. Clin. Microbiol. 1989;27:1490-1495.

    Not in our library10.1128/jcm.27.7.1490-1495.1989

  3. 3.

    Bankaitis E.D., Ha A., Kuo C.J., Magness S.T. Reserve stem cells in intestinal homeostasis and injury. Gastroenterology. 2018;155:1348-1361.

    Not in our library10.1053/j.gastro.2018.08.016

  4. 4.

    Behnke M.S., Khan A., Lauron E.J., Jimah J.R., Wang Q., Tolia N.H., Sibley L.D. Rhoptry proteins ROP5 and ROP18 are major murine virulence factors in genetically divergent South American strains of Toxoplasma gondii. PLoS Genet. 2015;11:e1005434.

    Not in our library10.1371/journal.pgen.1005434

  5. 5.

    Belli S.I., Ferguson D.J., Katrib M., Slapetova I., Mai K., Slapeta J., Flowers S.A., Miska K.B., Tomley F.M., Shirley M.W. Conservation of proteins involved in oocyst wall formation in Eimeria maxima, Eimeria tenella and Eimeria acervulina. Int. J. Parasitol. 2009;39:1063-1070.

    Not in our library10.1016/j.ijpara.2009.05.004

  6. 6.

    Bjerknes M., Khandanpour C., Möröy T., Fujiyama T., Hoshino M., Klisch T.J., Ding Q., Gan L., Wang J., Martín M.G. Origin of the brush cell lineage in the mouse intestinal epithelium. Dev. Biol. 2012;362:194-218.

    Not in our library10.1016/j.ydbio.2011.12.009

  7. 7.

    Cevallos A.M., Bhat N., Verdon R., Hamer D.H., Stein B., Tzipori S., Pereira M.E., Keusch G.T., Ward H.D. Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect. Immun. 2000;68:5167-5175.

    Not in our library10.1128/iai.68.9.5167-5175.2000

  8. 8.

    Chatterjee A., Banerjee S., Steffen M., O'Connor R.M., Ward H.D., Robbins P.W., Samuelson J. Evidence for mucin-like glycoproteins that tether sporozoites of Cryptosporidium parvum to the inner surface of the oocyst wall. Eukaryot. Cell. 2010;9:84-96.

    Not in our library10.1128/ec.00288-09

  9. 9.

    Current W.L., Reese N.C. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J. Protozool. 1986;33:98-108.

    Not in our library10.1111/j.1550-7408.1986.tb05567.x

  10. 10.

    DeCicco RePass M.A., Chen Y., Lin Y., Zhou W., Kaplan D.L., Ward H.D. Novel bioengineered three-dimensional human intestinal model for long-term infection of Cryptosporidium parvum. Infect. Immun. 2017;85.

    Not in our library10.1128/iai.00731-16

  11. 11.

    Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.

    Not in our library10.1093/bioinformatics/bts635

  12. 12.

    Doherty M., Todd D., McFerran N., Hoey E.M. Sequence analysis of a porcine enterovirus serotype 1 isolate: relationships with other picornaviruses. J. Gen. Virol. 1999;80:1929-1941.

    Not in our library10.1099/0022-1317-80-8-1929

  13. 13.

    Fayer R. Effect of sodium hypochlorite exposure on infectivity of Cryptosporidium parvum oocysts for neonatal BALB/c mice. Appl. Environ. Microbiol. 1995;61:844-846.

    Not in our library10.1128/aem.61.2.844-846.1995

  14. 14.

    Feng Y., Ryan U.M., Xiao L. Genetic diversity and population structure of cryptosporidium. Trends Parasitol. 2018;34:997-1011.

    Not in our library10.1016/j.pt.2018.07.009

  15. 15.

    Griffiths J.K., Theodos C., Paris M., Tzipori S. The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. J. Clin. Microbiol. 1998;36:2503-2508.

    Not in our library10.1128/jcm.36.9.2503-2508.1998

  16. 16.

    Heo I., Dutta D., Schaefer D.A., Iakobachvili N., Artegiani B., Sachs N., Boonekamp K.E., Bowden G., Hendrickx A.P.A., Willems R.J.L. Modelling Cryptosporidium infection in human small intestinal and lung organoids. Nat. Microbiol. 2018;3:814-823.

    Not in our library10.1038/s41564-018-0177-8

  17. 17.
  18. 18.

    Kotloff K.L. The burden and etiology of diarrheal illness in developing countries. Pediatr. Clin. North Am. 2017;64:799-814.

    Not in our library10.1016/j.pcl.2017.03.006

  19. 19.

    Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T.H., Panchalingam S., Wu Y., Sow S.O., Sur D., Breiman R.F. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209-222.

    Not in our library10.1016/s0140-6736(13)60844-2

  20. 20.

    Kuhlenschmidt T.B., Rutaganira F.U., Long S., Tang K., Shokat K.M., Kuhlenschmidt M.S., Sibley L.D. Inhibition of calcium-dependent protein kinase 1 (CDPK1) in vitro by Pyrazolopyrimidine derivatives does not correlate with sensitivity of Cryptosporidium parvum growth in cell culture. Antimicrob. Agents Chemother. 2015;60:570-579.

    Not in our library10.1128/aac.01915-15

  21. 21.

    Mai K., Sharman P.K., Walker R.A., Katrib M., De Souza D., McConville M.J., Wallach M.G., Belli S.I., Ferguson D.J., Smith N.C. Oocyst wall formation and composition in coccidian parasites. Mem. Inst. Oswaldo Cruz. 2009;104:281-289.

    Not in our library10.1590/s0074-02762009000200022

  22. 22.

    Miyoshi H., Ajima R., Luo C.T., Yamaguchi T.P., Stappenbeck T.S. Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338:108-113.

    Not in our library10.1126/science.1223821

  23. 23.

    Miyoshi H., Stappenbeck T.S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 2013;8:2471-2482.

    Not in our library10.1038/nprot.2013.153

  24. 24.

    Moon C., VanDussen K.L., Miyoshi H., Stappenbeck T.S. Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis. Mucosal Immunol. 2014;7:818-828.

    Not in our library10.1038/mi.2013.98

  25. 25.

    Moore R., Tzipori S., Griffiths J.K., Johnson K., De Montigny L., Lomakina I. Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology. 1995;108:1030-1039.

    Not in our library10.1016/0016-5085(95)90200-7

  26. 26.

    Morada M., Lee S., Gunther-Cummins L., Weiss L.M., Widmer G., Tzipori S., Yarlett N. Continuous culture of Cryptosporidium parvum using hollow fiber technology. Int. J. Parasitol. 2016;46:21-29.

    Not in our library10.1016/j.ijpara.2015.07.006

  27. 27.

    O'Connor R.M., Shaffie R., Kang G., Ward H.D. Cryptosporidiosis in patients with HIV/AIDS. AIDS. 2011;25:549-560.

    Not in our library10.1097/qad.0b013e3283437e88

  28. 28.

    Pawlowic M.C., Vinayak S., Sateriale A., Brooks C.F., Striepen B. Generating and maintaining transgenic Cryptosporidium parvum parasites. Curr. Protoc. Microbiol. 2017;46:20B 2.1-20B 2.32.

    Not in our library10.1002/cpmc.33

  29. 29.

    Pereira S.J., Ramirez N.E., Xiao L., Ward L.A. Pathogenesis of human and bovine Cryptosporidium parvum in gnotobiotic pigs. J. Infect. Dis. 2002;186:715-718.

    Not in our library10.1086/342296

  30. 30.

    Potter M., Newport E., Morten K.J. The Warburg effect: 80 years on. Biochem. Soc. Trans. 2016;44:1499-1505.

    Not in our library10.1042/bst20160094

  31. 31.

    Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676-682.

    Not in our library10.1038/nmeth.2019

  32. 32.

    Schurko A.M., Logsdon J.M. Using a meiosis detection toolkit to investigate ancient asexual "scandals" and the evolution of sex. BioEssays. 2008;30:579-589.

    Not in our library10.1002/bies.20764

  33. 33.
  34. 34.

    Shroyer N.F., Helmrath M.A., Wang V.Y., Antalffy B., Henning S.J., Zoghbi H.Y. Intestine-specific ablation of mouse atonal homolog 1 (Math1) reveals a role in cellular homeostasis. Gastroenterology. 2007;132:2478-2488.

    Not in our library10.1053/j.gastro.2007.03.047

  35. 35.

    Spano F., Puri C., Ranucci L., Putignani L., Crisanti A. Cloning of the entire COWP gene of Cryptosporidium parvum and ultrastructural localization of the protein during sexual parasite development. Parasitology. 1997;114:427-437.

    Not in our library10.1017/s0031182096008761

  36. 36.

    Striepen B., Pruijssers A.J., Huang J., Li C., Gubbels M.J., Umejiego N.N., Hedstrom L., Kissinger J.C. Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc. Natl. Acad. Sci. USA. 2004;101:3154-3159.

    Not in our library10.1073/pnas.0304686101

  37. 37.

    Tang X., Liu X., Tao G., Qin M., Yin G., Suo J., Suo X. Self-cleaving" 2A peptide from porcine teschovirus-1 mediates cleavage of dual fluorescent proteins in transgenic Eimeria tenella. Vet. Res. 2016;47:68.

    Not in our library10.1186/s13567-016-0351-z

  38. 38.

    Thulin J.D., Kuhlenschmidt M.S., Rolsma M.D., Current W.L., Gelberg H.B. An intestinal zenograph model for Cryptosporidium parvum infection. Infect. Immun. 1994;62:329-331.

    Not in our library10.1128/iai.62.1.329-331.1994

  39. 39.

    Tzipori S., Griffiths J.K. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 1998;40:5-36.

    Not in our library10.1016/s0065-308x(08)60116-5

  40. 40.

    Upton S.J., Tilley M., Brillhart D.B. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 1994;118:233-236.

    Not in our library10.1111/j.1574-6968.1994.tb06833.x

  41. 41.

    VanDussen K.L., Marinshaw J.M., Shaikh N., Miyoshi H., Moon C.S., Tarr P.I., Ciorba M.A., Stappenbeck T.S. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut. 2015;64:911-920.

    Not in our library10.1136/gutjnl-2013-306651

  42. 42.

    VanDussen K.L., Sonnek N.M., Stappenbeck T.S. L-WRN conditioned medium for gastrointestinal epithelial stem cell culture shows replicable batch-to-batch activity levels across multiple research teams. Stem Cell Res. 2019;37:101430.

    Not in our library10.1016/j.scr.2019.101430

  43. 43.

    Vinayak S., Pawlowic M.C., Sateriale A., Brooks C.F., Studstill C.J., Bar-Peled Y., Cipriano M.J., Striepen B. Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. Nature. 2015;523:477-480.

    Not in our library10.1038/nature14651

  44. 44.

    von Oettingen J., Nath-Chowdhury M., Ward B.J., Rodloff A.C., Arrowood M.J., Ndao M. High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice. Parasitology. 2008;135:1151-1156.

    Not in our library10.1017/s0031182008004757

  45. 45.

    Wang X., Yamamoto Y., Wilson L.H., Zhang T., Howitt B.E., Farrow M.A., Kern F., Ning G., Hong Y., Khor C.C. Cloning and variation of ground state intestinal stem cells. Nature. 2015;522:173-178.

    Not in our library10.1038/nature14484

  46. 46.

    Wilke G., Ravindran S., Funkhouser-Jones L., Barks J., Wang Q., VanDussen K.L., Stappenbeck T.S., Kuhlenschmidt T.B., Kuhlenschmidt M.S., Sibley L.D. Monoclonal antibodies to intracellular stages of Cryptosporidium parvum define life cycle progression in vitro. mSphere. 2018;3.

    Not in our library10.1128/msphere.00124-18

  47. 47.

    Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001;294:2155-2158.

    Not in our library10.1126/science.1065718

  48. 48.

    Zhang X., Kim C.Y., Worthen T., Witola W.H. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity. Int. J. Parasitol. 2018;48:649-656.

    Not in our library10.1016/j.ijpara.2018.01.005

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.